Home › Funds › AWM Investment Company, Inc. › RANI

AWM Investment Company, Inc. position in RANI

Rani Therapeutics Holdings Inc · Health Care

AWM Investment Company, Inc. reported holding 7,500,000 shares of RANI (Rani Therapeutics Holdings Inc) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.57% of its reported portfolio and ranking #50 among its reported holdings. AWM Investment Company, Inc. has disclosed RANI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)7.50M sh
Reported value held$5.93M
Portfolio Weight0.57%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How AWM Investment Company, Inc.'s RANI position evolved

AWM Investment Company, Inc. first disclosed a stake in RANI in Q4 2025 at 6,500,000 shares (US$8.8M). Across 4 filings, AWM Investment Company, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 7,500,000 shares valued at US$5.9M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 6.50M $8.78M New
Q1 2026 6.50M $4.78M Hold
Q2 2026 7.50M $5.70M Add
Q3 2026 7.50M $5.93M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RANI and 13F data

RANI (Rani Therapeutics Holdings Inc) is a Health Care company. 32 other funds we track also report a position in RANI — the largest reported positions include Samsara BioCapital, LLC (US$7.9M), SymBiosis Capital Partners, LLC (US$2.7M), Nan Fung Group Holdings Ltd (US$390K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RANI

All RANI fund holders →

FAQ

How long has AWM Investment Company, Inc. held RANI?

AWM Investment Company, Inc. has disclosed RANI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is AWM Investment Company, Inc.'s current position in RANI?

As of Q3 2026, AWM Investment Company, Inc. holds 7.50M shares of RANI (Rani Therapeutics Holdings Inc), valued at $5.93M, representing 0.57% of its reported portfolio and ranking #50.

Has AWM Investment Company, Inc. been buying or selling RANI?

In the latest 13F filing (Q3 2026), AWM Investment Company, Inc. held unchanged its position in RANI.

Which other funds hold RANI?

Other major institutional holders of RANI include Samsara BioCapital, LLC, SymBiosis Capital Partners, LLC, Nan Fung Group Holdings Ltd, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.